USPTO serial 79457737
GS ORI-GO
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- TMO LAW OFFICE 119
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with GS ORI-GO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cells for scientific, laboratory, medical research and clinical use including genetic material for protein production; biological preparations, not for medical use, namely, genetically modified cells and vectors for production of human, animal and synthetic proteins, for clinical and commercial use in scientific research, and for use in pharmaceutical research; kits consisting of cell lines, reagents, enzyme substrates and/or genetically modified chemical preparations; reagents, nucleic acids and nucleotides for scientific use and for research purposes in the field of clinical research, drug development, research in agriculture and genetics; reagent kits consisting of reagents and chemical preparations; samples of nucleotide sequence variants and modifications for use in the field of scientific research, clinical research and scientific research in diagnosis. | ACTIVE | — |
| 005 | Biological preparations, for medical use, namely, genetically modified cells and genetically modified vectors for production of human, animal and synthetic proteins for medical purposes and, for clinical and commercial use in human and animal therapies; Gene therapy products, namely, modified cells and modified cell platforms. | ACTIVE | — |
| 042 | Scientific and medical research in the field of biotechnology; Technical consultancy and project planning in the field of biological research relating to proteins; research and development in the field of proteins for others; scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of pharmaceutical and biological preparations for human and veterinary use; aggregating, analyzing and providing data in the field of genomics; custom design and development of cell lines designed for others for scientific research, drug discovery and development; scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of medical diagnostic products. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 5, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 10, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |